Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 174

    1.

    Psyllium therapy in the irritable bowel syndrome. A double-blind trial.

    Longstreth GF, Fox DD, Youkeles L, Forsythe AB, Wolochow DA.

    Ann Intern Med. 1981 Jul;95(1):53-6.PMID: 7018336 [PubMed - indexed for MEDLINE]Related articles

    2.

    Double blind study of ispaghula in irritable bowel syndrome.

    Prior A, Whorwell PJ.

    Gut. 1987 Nov;28(11):1510-3.PMID: 3322956 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Ispaghula therapy in irritable bowel syndrome: improvement in overall well-being is related to reduction in bowel dissatisfaction.

    Jalihal A, Kurian G.

    J Gastroenterol Hepatol. 1990 Sep-Oct;5(5):507-13.PMID: 2129822 [PubMed - indexed for MEDLINE]Related articles

    4.

    Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial.

    Madisch A, Holtmann G, Plein K, Hotz J.

    Aliment Pharmacol Ther. 2004 Feb 1;19(3):271-9.PMID: 14984373 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Loperamide in treatment of irritable bowel syndrome--a double-blind placebo controlled study.

    Lavö B, Stenstam M, Nielsen AL.

    Scand J Gastroenterol Suppl. 1987;130:77-80.PMID: 3306903 [PubMed - indexed for MEDLINE]Related articles

    6.

    Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome.

    Centonze V, Imbimbo BP, Campanozzi F, Attolini E, Daniotti S, Albano O.

    Am J Gastroenterol. 1988 Nov;83(11):1262-6.PMID: 3055943 [PubMed - indexed for MEDLINE]Related articles

    7.

    [The efficacy of Plantago ovata as a regulator of intestinal transit. A double-blind study compared to placebo]

    Tomás-Ridocci M, Añón R, Mínguez M, Zaragoza A, Ballester J, Benages A.

    Rev Esp Enferm Dig. 1992 Jul;82(1):17-22. Spanish. PMID: 1520545 [PubMed - indexed for MEDLINE]Related articles

    8.

    Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study.

    Battaglia G, Morselli-Labate AM, Camarri E, Francavilla A, De Marco F, Mastropaolo G, Naccarato R.

    Aliment Pharmacol Ther. 1998 Oct;12(10):1003-10.PMID: 9798806 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation.

    Novick J, Miner P, Krause R, Glebas K, Bliesath H, Ligozio G, Rüegg P, Lefkowitz M.

    Aliment Pharmacol Ther. 2002 Nov;16(11):1877-88.PMID: 12390096 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome.

    Talley NJ, Phillips SF, Bruce B, Twomey CK, Zinsmeister AR, Melton LJ 3rd.

    Gastroenterology. 1990 Aug;99(2):327-33.PMID: 2365186 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Effectiveness of plantago seed husks in comparison with wheat brain on stool frequency and manifestations of irritable colon syndrome with constipation]

    Hotz J, Plein K.

    Med Klin (Munich). 1994 Dec 15;89(12):645-51. German. PMID: 7869999 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Effect of a buzepide metiodide-haloperidol combination in treating functional intestinal disorders. Randomized double-blind controlled versus placebo study]

    Barbier JP, Dorf G, Gordin J, Krainik F, Neveu D, Parlier H, Richard P, Vitaux J, Fraitag B.

    Ann Gastroenterol Hepatol (Paris). 1989 May;25(3):123-8. French. PMID: 2672998 [PubMed - indexed for MEDLINE]Related articles

    13.

    Loperamide treatment of the irritable bowel syndrome.

    Hovdenak N.

    Scand J Gastroenterol Suppl. 1987;130:81-4.PMID: 3306904 [PubMed - indexed for MEDLINE]Related articles

    14.

    Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled trial.

    Mitchell SA, Mee AS, Smith GD, Palmer KR, Chapman RW.

    Aliment Pharmacol Ther. 2002 Jun;16(6):1187-95.PMID: 12030962 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome.

    Poynard T, Naveau S, Mory B, Chaput JC.

    Aliment Pharmacol Ther. 1994 Oct;8(5):499-510.PMID: 7865642 [PubMed - indexed for MEDLINE]Related articles

    16.

    Symptom relief with amitriptyline in the irritable bowel syndrome.

    Rajagopalan M, Kurian G, John J.

    J Gastroenterol Hepatol. 1998 Jul;13(7):738-41.PMID: 9715427 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome.

    Kruis W, Weinzierl M, Schüssler P, Holl J.

    Digestion. 1986;34(3):196-201.PMID: 3019810 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.

    Delvaux M, Louvel D, Mamet JP, Campos-Oriola R, Frexinos J.

    Aliment Pharmacol Ther. 1998 Sep;12(9):849-55.PMID: 9768527 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A double-blind trial of a celandin, aloevera and psyllium laxative preparation in adult patients with constipation.

    Odes HS, Madar Z.

    Digestion. 1991;49(2):65-71.PMID: 1800188 [PubMed - indexed for MEDLINE]Related articles

    20.

    An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome.

    Kellow J, Lee OY, Chang FY, Thongsawat S, Mazlam MZ, Yuen H, Gwee KA, Bak YT, Jones J, Wagner A.

    Gut. 2003 May;52(5):671-6.PMID: 12692051 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data